Cencora Raises FY26 Outlook; Plans Up To $2 Bln Addl. Share Repurchase
22/5 10:33
(RTTNews) - Cencora Inc. (COR), a pharmaceutical company, announced that it has raised the lower end of its fiscal 2026 adjusted earnings outlook. Further, the company said its Board of Directors, on May 20th, authorized additional up to $2.0 billion share repurchase program....